Etravirina en primeras líneas de tratamiento

Arazo Garcés, Piedad; Valero Tena, Esther.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 27(supl.2): 12-20, dic. 2009. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-179465

Documentos relacionados

  1. Preparation of a Key Intermediate En Route to the Anti-HIV Drug Lenacapavir.
  2. Strategies for an HIV cure: progress and challenges.
  3. Design and Synthesis of New GS-6207 Subtypes for Targeting HIV-1 Capsid Protein.
  4. Molecular basis of RNA recognition by TBP of HIV-1 from multiple molecular dynamics simulations and energy predictions.
  5. Achieving UNAIDS Viral Suppression Goal: Experience from a Tertiary Care Public Hospital, Western India.
  6. Synthesis and Biological Evaluation of 5'-<i>O</i>-Fatty Acyl Ester Derivatives of 3'-Fluoro-2',3'-dideoxythymidine as Potential Anti-HIV Microbicides.
  7. Lenacapavir: A Novel Long-Acting Capsid Inhibitor for HIV.
  8. Low-level viral loads and virological failure in the integrase strand transfer era.
  9. Exploring concentration response in HIV pre-exposure prophylaxis to optimize clinical care and trial design.
  10. Getting HIV Pre-exposure Prophylaxis (PrEP) into Private Pharmacies: Global Delivery Models and Research Directions.